Refine
Estimated Years 2020-2029Clear
2,151 results foundRefine Search
SOCIO-ECONOMIC CONTRIBUTION OF THE EUROPEAN COSMETICS INDUSTRY EUROPE IS A GLOBAL FLAGSHIP MARKET FOR COSMETIC PRODUCTS Europe* 88bn US 97bn Brazil 23bn *EU-27, Norway, Switzerland & UK Japan 27bn South Korea 11bn China 71bn India 14bn SKIN CARE & TOILETRIES: largest share of the European market (2022) 25.6bn Skin Care 21.5bn Toiletries 15.7bn Hair Care 14.0bn Fragrances & Perfumes Cosmetics Europe, Market Performance Report 2022. 11.5bn Decorative Cosmetics > 44bn trade in cosmetic products within Europe in 2022 > 26bn total export of cosmetic products from Europe in 2022 France & Germany: Europe's main exporters Over 50% of total global exports from Europe SMES & BIG COMPANIES ARE KEY DRIVERS OF INNOVATION & ECONOMIC GROWTH IN THE INDUSTRY More than 8,500 SMEs THE NUMBER IS GROWING The UK, France & Poland have the largest number of SMEs; followed by Italy and Spain 1413 1389 604 Cosmetics Europe, Market Performance Report 2022. 786 776 THE INDUSTRY SUPPORTS MILLIONS OF EUROPEAN JOBS UP & DOWN THE VALUE CHAIN Over 3 MILLION JOBS across Europe 254,259 people employed directly 2,778,674 people employed indirectly >606,000 people employed through induced effects Cosmetics Europe, Market Performance Report 2022.
Document image
refid# LJ1Mmnw5rGjB8N89K7gjqkORw1 page
September 2023 AGC's CONTRIBUTION TO THE CONSULTATION ON THE RESTRICTION PROPOSAL ON PFAS AS REGARDS GENERAL COMMENTS AND GENERAL INFORMATION ON FLUOROPOLYMERS NON-CONFIDENTIAL Table of Contents Table of Contents ............................................................................................................1 Introduction ...................................................................................................................... 2 Part 1.
Document imageDocument imageDocument imageDocument image
refid# 828exwwkaL3gpG3VpazoeOwGK37 pages
PFAS restrictions and their consequences for EU textile manufacturers Chem-Academy Bonn, 2023-06-27 Stefan Thumm Dipl.
Document imageDocument imageDocument imageDocument image
refid# 0JK1oQ7x6yGowvZ9BKRnJY1Nm18 pages
FSSA ECHA Science 25 September 2023 Executive Summary FSSA supports rational, science-based efforts to eliminate sources of harm to humans and the environment.
Document imageDocument imageDocument imageDocument image
refid# peRq93dqwB5RLyJJ366JnoRYw10 pages
Deadline Who 11/12/2020 Ramboll/ECHA 18/12/2020 Task ref SC2 (ECHA/2020/839) Universal PFAS restriction CfE summary table 28.02.2020 Ramboll/ECHA SC3 (ECHA/2020/875) emissions and costs over time 15.03.2020 Ramboll/ECHA SC5 (ECHA/2020/877) manufacturing/ export 22.03.2020 Ramboll/ECHA SC4 (ECHA/2020/876) disposal and cleaning Task description Deliverable: An Excel sheet with at least, for each of the 82 comments: - the name of the comment file - a summary of the comment (if short and focused) or a list of topics addressed (if long and covering several issues), highlighting if the comment is claimed confidential or not by segregating comments in two columns Deliverable: 1.
Document imageDocument imageDocument image
refid# N271wJapZa91EEByEmKvpLGDD3 pages
Draft agenda for PFAS-RESTRICTION WEBEX Meeting between DE, DK, NL, NO, SE CA and ECHA 24 August 2020, 9 am - 1 pm (CET) Login details: See below Point 1 - Opening and adoption of the agenda (9:00-9:10 am) Point 2 - Minutes and action points (9:10 - 9:20 am) 2020-07-14_PFAS RESTR-7 Minutes and APs_Draft of FINAL.docx 2020-08-19_Continued list of Action Points and their status.docx Point 3 - WP1 RMOA and call for evidence (9:20 - 11 am) Sharing of documents: See E-Mail from 03.08.2020 and documents on S-CIRCABC - Masterfile containing all responses received in CfE via questionnaire (please note that independent responses via E-Mail are not contained!)
Document imageDocument imageDocument image
refid# g2DO3x0vk1jo2KKv9B21oLqjJ3 pages
FINAL REPORT Hydrothermal Technologies for On-Site Destruction of Site Investigation Wastes Contaminated with Per- and Polyfluoroalkyl Substances (PFAS) SERDP Project ER18-1501 SEPTEMBER 2020 Timothy J.
Document imageDocument imageDocument imageDocument image
refid# jg6YyB80DE3VbDbnRej9qKyjN89 pages
background // november 2021 Reducing the input of chemicals into waters: trifluoroacetate (TFA) as a persistent and mobile substance with many sources German Environment Agency Imprint Publisher: Umweltbundesamt (German Environment Agency) Section IV 1.3 Plant Protection Products PO Box 14 06 D-06813 Dessau-Rolau Tel: +49 340-2103-0 @uba.de Internet: www.umweltbundesamt.de el /umweltbundesamt.de je /umweltbundesamt CI /umweltbundesamt 0 /umweltbundesamt Authors: Kirsten Ad[Linger, Julia M.
Document imageDocument imageDocument imageDocument image
refid# 6bd4vD47v4bY0mn5dQonZg2D652 pages
To Eminent ECHA - European Chemical Agency's Committees 23 May 2023 SUBJECT: PFAS RESTRICTION Public Consultation_SECTION IV.
Document imageDocument imageDocument imageDocument image
refid# 99Kx5dkzVB568Ben3prowR2Gq6 pages
EUROMOT Brussels, Belgium i ne impact of a Potential PFAS Restriction on Internal Combustion Engine and Alternative Powertrain Manufacturers Report No. 2023-0368 Rev. 0 Project No.
Document imageDocument imageDocument imageDocument image
refid# eMjJqMEpn9q25KmXJ8QLNb2y44 pages
PEEK vs PTFE Analysis as a viable alternative PEEK vs PTFE polymer - Report on the analysis as a viable alternative 1.
Document imageDocument imageDocument imageDocument image
refid# rx6jqjvYbJLnMBd9Z2mQrj2D715 pages
PFAS-Containing Surfactants Used in Semiconductor Manufacturing Semiconductor PFAS Consortium Photolithography Working Group June 2, 2023 Acknowledgments: The PFAS Consortium would like to acknowledge the contributions of the Semiconductor PFAS Consortium Photolithography Technical Working Group for their efforts to compile this information.
Document imageDocument imageDocument imageDocument image
refid# q3Qnv30aq7ymbXybL0GJ3dBwK17 pages
a.
Document imageDocument imageDocument imageDocument image
refid# Nepmkd3qEvK5XKye4qgoMBkkQ12 pages
Introduction MedTech Europe, the European voice of the medical technology industry including diagnostics, medical devices and (PFAS), as published in January 2023 and subject to initial exchange at ECHA's scientific committees for Risk Asse MedTech Europe is committed to the ambition of the EU Chemicals Strategy for Sustainability to boost innovation fo to improve the performance of its products and processes, including through the phase out of uses of PFAS where t PFAS in the medical technology sector Where PFAS uses occur in the medical technology sector, this is due to their unique performance and combination either in a component or coating of the final medical device (MD) or in vitro diagnostic device (IVD), including inves or as a processing aid used during device or upstream manufacturing; or in the device part of an integral drug device combination, or as cell replacement therapies, or biomaterials, PFAS substances play a key role in achieving the required high performance and durability of the technologies whic (MDs) and Regulation (EU) 2017/746 on In-Vitro Diagnostics (IVDs).
Document imageDocument imageDocument imageDocument image
refid# nkR7NDR6ex56e2X8vx9bQL5Vz578 pages
Comment on Proposed Restriction of PFAS May 25, 2023 Japan Fluoropolymers Industry Association (JFIA) We, Japan Fluoropolymers Industry Association (JFIA), think that fluoropolymers should be distinguished from the proposed restriction of PFAS (Per- and polyfluoroalkyl substances), which collectively regulates more than 10,000 of organofluorine compounds (PFAS) on the grouping basis.
Document imageDocument imageDocument imageDocument image
refid# ZJBbwXxxOGvJxMgEn2bYQbYqL12 pages